RESUMEN
ST121/agr-IV methicillin-susceptible Staphylococcus aureus was isolated from a patient of septic arthritis (synovial fluid, blood, skin and nasal cavity). Although the Panton-Valentine leukocidin (PVL) gene was negative, this isolate harboured a gene encoding a variant of bone sialoprotein-binding protein with a shortened SD-repeat region.
RESUMEN
A methicillin-susceptible Staphylococcus aureus with Panton-Valentine leukocidin (PVL) genes was isolated from refractory breast abscesses of 12-year-old girl in Japan, and classified into ST88, spa-t1245 and coa-IIIa. This strain harboured PVL phage ΦSa2usa, which is usually found in ST8 community-acquired methicillin-resistant S. aureus clone USA300.
RESUMEN
OBJECTIVES: To examine the influences of design and finishing on mouthguard wearability and retention. MATERIALS AND METHODS: 17 students at the Dental Technician Institute at Osaka University School of Dentistry, Osaka, Japan, participated in this study after providing informed consent. For each student, a single-layer custom-made mouthguard was fabricated from a 3.8-mm-thick ethylene-vinyl acetate sheet using a standardised procedure to obtain a precise fit. Each mouthguard was modified by changing the margin location and shape through five consecutive steps. At each step, questionnaires with a visual analogue scale regarding wearability (comfort, breathing, speaking, swallowing, lip closure, temporomandibular joint fatigue and swallowing) and retention were completed by subjects after wearing the mouthguard for 5 min. Statistical analyses were carried out among the steps using Wilcoxon's signed-rank test with a significance level of p<0.05. RESULTS: Significant improvements were found for comfort, breathing, speaking and swallowing by trimming the palatal margin to the cervical area, smooth finishing and occlusal adjustment of the mouthguard (p<0.01). No significant differences were found for retention throughout the procedure. CONCLUSIONS: Within the limitations of this experimental study, design and finishing at the palatal side appear to have significant influences on mouthguard wearability, but not retention.
Asunto(s)
Traumatismos en Atletas/prevención & control , Protectores Bucales/normas , Deportes , Adulto , Comportamiento del Consumidor , Deglución , Diseño de Equipo , Femenino , Humanos , Masculino , Dimensión del Dolor , Hueso PaladarRESUMEN
Effective presentation of tumor antigens by dendritic cells (DCs) is considered to be essential for the induction of antitumor T-cell responses. Apoptotic and necrotic tumors have been noted to be a robust antigen source for DCs. Because glioma cells undergo apoptosis after transfection with the type I interferon (IFN) gene and type I IFNs promote the stimulatory activity of DCs, we hypothesized that transfection of glioma cells with type I IFN genes and provision of DCs would promote particularly effective antitumor activity by both facilitating apoptosis of glioma cells and the presentation of the glioma antigens, thereby inducing specific immune responses against glioma cells. We have previously reported the proof of this hypothesis in vitro and in a subcutaneous tumor model. Here we report an extension of this approach in intracranial (i.c.) gliomas using adenoviral IFN-alpha (Ad-IFN-alpha) vector. Mice bearing day-5 i.c. GL261 glioma received sequential intratumoral (i.t.) delivery of Ad-IFN-alpha and bone marrow-derived syngeneic DCs. This treatment prolonged survival in that nine of 17 animals survived long term (> 60 days versus 0 of 10 control animals). Specific CTL activity was demonstrated following this regimen in the cervical lymph nodes, and the therapeutic efficacy was dependent upon CD8+ cells. Furthermore, these animals were protected against subsequent re-challenge with GL261 gliomas. DCs injected i.t. survived in the tumor and migrated into cervical lymph node. In vitro migration assays revealed the ability of DCs to migrate toward the tumor, suggesting that i.t. injected DCs migrate through the glioma. Taken together, this combination of gene therapy and cellular immunotherapy may be an effective future strategy for treating human gliomas.
Asunto(s)
Neoplasias Encefálicas/terapia , Células Dendríticas/trasplante , Terapia Genética/métodos , Glioma/terapia , Inmunoterapia Adoptiva/métodos , Interferón-alfa/genética , Adenoviridae/genética , Animales , Antígenos de Neoplasias/inmunología , Apoptosis , Neoplasias Encefálicas/inmunología , Células Dendríticas/inmunología , Femenino , Vectores Genéticos/administración & dosificación , Glioma/inmunología , Inyecciones Intralesiones , Ratones , Ratones Endogámicos C57BL , Neoplasias Experimentales , Linfocitos T Citotóxicos/inmunología , Transducción Genética/métodosRESUMEN
Splenosis is autotransplantation of splenic tissue that usually follows traumatic rupture of the spleen and/or splenectomy. We report a case of retroperitoneal splenosis. The correct diagnosis was made noninvasively with Tc-99m heat-damaged red blood cell scintigraphy. Surgical treatment, which was not necessary in this patient, could be avoided by splenic scintigraphy.
Asunto(s)
Eritrocitos , Radiofármacos , Pertecnetato de Sodio Tc 99m , Esplenosis/diagnóstico por imagen , Adulto , Calor , Humanos , Masculino , Cintigrafía , Espacio RetroperitonealRESUMEN
Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that locate in peripheral organs. It has been thought that a systemic immune response does not play a role in regression of central nervous system (CNS) tumors, because the CNS is an immunologically privileged site. However, recent advances in immunology have led to the possibility of immunotherapy using peripheral DCs against CNS tumors. Here, we investigated whether DCs pulsed with tumor extract could induce an antitumor effect against malignant glioma. Furthermore, we also investigated whether the antitumor effect become higher by pulsation with tumor extract-liposome complex, compared to pulsation with tumor extract alone. As a liposome, we used cationic small unilamellar vesicles composed of N-(alpha-trimethylammonioacetyl)-didodecyl-D-glutamate chloride (TMAG), dilauroylphosphatidylcholine (DLPC), and dioleoylphosphatidylethanolamine (DOPE) in a molar ratio of 1:2:2. After intracerebral inoculation of mouse malignant glioma GL261 cells into syngeneic C57BL/6 mice, DCs pulsed with extract from the glioma cells by sonication were administered intraperitoneally thrice weekly on days 7, 14 and 21. Tumor growth inhibition was evaluated by measuring the tumor size 1 month after the tumor inoculation. The group treated with DCs pulsed by tumor extract was inhibited in tumor progression compared with the control non-pulsed DCs group, and the group treated with DCs pulsed by tumor extract and liposomes showed substantial tumor volume reductions in all the mice. Among the mice, there were several with no visible masses in their brains. Immunohistochemical study showed that the CD8-positive cytotoxic T cells (CTLs) were strongly recognized among the almost disappearing tumor cells of pulsed DCs groups. The CTLs showed a specific antitumor activity for GL261 mouse glioma cells. These findings indicated that DCs pulsed with tumor extract and liposomes might play an important role in the activation of an immune response in malignant glioma.
Asunto(s)
Neoplasias Encefálicas/inmunología , Células Dendríticas/inmunología , Glioma/inmunología , Linfocitos T Citotóxicos/inmunología , Animales , Neoplasias Encefálicas/prevención & control , Citotoxicidad Inmunológica , Células Dendríticas/efectos de los fármacos , Femenino , Glioma/prevención & control , Técnicas para Inmunoenzimas , Inmunoterapia , Liposomas , Ratones , Ratones Endogámicos C57BL , VacunaciónRESUMEN
Free radicals and lipid peroxide (LPO), easily formed in the diabetic state, play an important role in the development of diabetic complications. Potentially, nicorandil may reduce the production of free radicals and LPO in various organs. In fact, increased LPO levels in the serum, kidney, and cardiac muscle of diabetic (DM) rats were reduced by nicorandil treatment (N treatment). Xanthine oxidase (XOD), which produces free radicals, was decreased in the liver and increased in the kidney of DM rats compared with control rats, and these changes were prevented by N treatment. The concentration of Cu, Zn-superoxide dismutase (SOD) decreased in the cardiac muscle and increased in the kidney of DM rats, and these changes returned to normal after N treatment. The decreased concentration of Mn-SOD in the liver, kidney, and cardiac muscle from DM rats was also reversed by N treatment. The changes in catalase and glutathione peroxidase (GSH-PX) activities in DM rats were not improved effectively by N treatment. Another K-adenosine triphosphate (K-ATP) channel opener, tilisolol hydrochloride, had an effect similar to that of nicorandil. The effects of nicorandil and tilisolol were studied only in DM rats. These data imply that N treatment, as an antioxidative therapy, may be beneficial in preventing diabetic complications due to lipoperoxidation and free radicals in DM rats.
Asunto(s)
Diabetes Mellitus Experimental/metabolismo , Depuradores de Radicales Libres/farmacología , Peróxidos Lipídicos/metabolismo , Nicorandil/farmacología , Especies Reactivas de Oxígeno/metabolismo , Animales , Isoquinolinas/farmacología , Riñón/enzimología , Riñón/metabolismo , Peróxidos Lipídicos/sangre , Hígado/enzimología , Hígado/metabolismo , Masculino , Concentración Osmolar , Músculos Papilares/enzimología , Músculos Papilares/metabolismo , Canales de Potasio/efectos de los fármacos , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo , Xantina Oxidasa/metabolismoRESUMEN
Free radicals, hydroxyperoxides and H(2)O(2) are all known to damage cell components. This study was designed to compare the concentrations of hydroxyperoxide and free radical scavengers in the cardiac muscles of old rats in the hyper- or hypothyroid condition, to determine whether rates of peroxidation would differ with age, thyroid status, or both. Rats were rendered hyper- or hypothyroid by administration of l-thyroxine or methimazole for 4 weeks. Among the old rats, the lipid peroxide (LPO) concentrations, measured as thiobarbituric acid (TBA) reactants, were significantly greater in the hyperthyroid than in the euthyroid state and the LPO concentrations measured as TBA+Fe(3+) reactants, which may be precursors of LPO, were significantly greater in the hyperthyroid state, whereas in young rats, the LPO concentrations measured by TBA or TBA+Fe(3+) methods did not differ significantly in the hyperthyroid state. In the euthyroid state, the concentration of LPO measured as TBA+Fe(3+) reactants was significantly reduced with age. Xanthine oxidase (XOD) activity also was markedly increased with age, being more pronounced in the hyperthyroid than in the euthyroid state. The Mn and Cu/Zn superoxide dismutase activities were greater in the hyperthyroid than in the euthyroid state. Glutathione peroxidase activity decreased with age in the euthyroid and, particularly, in the hyperthyroid state. Catalase activity was not affected in the old rats. Concentrations of alpha-tocopherol in the old rats were high in the hyperthyroid state and low in the hypothyroid state, whereas the levels of beta- and gamma-tocopherols in these rats were unchanged in both conditions as compared with the euthyroid state findings. Data suggest that the site of free radical generation differs in older rats, with additional shifts in the location of intracellular lipid peroxidation being noted during hyperthyroidism. Thus, as rats age, the reduction of the free radical scavenger system and the increase in LPO and XOD activities might induce myocardial dysfunction.
Asunto(s)
Envejecimiento/fisiología , Miocardio/metabolismo , Enfermedades de la Tiroides/metabolismo , Glándula Tiroides/metabolismo , Análisis de Varianza , Animales , Antitiroideos , Glutatión Peroxidasa/metabolismo , Hipertiroidismo/metabolismo , Hipotiroidismo/metabolismo , Peroxidación de Lípido , Masculino , Malondialdehído/metabolismo , Metimazol , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo , Tiroxina , Vitamina E/metabolismo , Xantina Oxidasa/metabolismoRESUMEN
The aim of this study was to determine whether chemo-endocrine therapy after the resection of liver metastasis from colorectal cancer would prevent recurrence in the remnant liver and prolong survival. Eleven colorectal cancer patients underwent hepatic resection for liver metastasis. Subsequently, they were administered Proglumide gastrin antagonist 1,200 mg/day + 5'-DFUR 800 mg/day for 2 years. In seven of them, MMC 6-10 mg and ADM 20 mg were infused intra-arterially every two weeks alternately for one year. In four of them, 5-FU 250 mg/day was infused for seven days continuously intra-arterially every two weeks for one year. Recurrence in the remnant liver occurred in four of 11 patients. All of these patients underwent repeated hepatectomy. The mean disease-free survival in the remnant liver was 37 months and the five-year survival rate was 91%. These results indicate that intra-arterial chemotherapy with gastrin receptor antagonist might be effective for adjuvant therapy in patients with resectable liver metastasis from colorectal cancer.
Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias Colorrectales/patología , Neoplasias Hepáticas/prevención & control , Neoplasias Hepáticas/secundario , Receptores de Colecistoquinina/antagonistas & inhibidores , Quimioterapia Adyuvante , Doxorrubicina/administración & dosificación , Esquema de Medicación , Floxuridina/administración & dosificación , Hepatectomía , Arteria Hepática , Humanos , Infusiones Intraarteriales , Neoplasias Hepáticas/cirugía , Mitomicina/administración & dosificación , Proglumida/administración & dosificaciónRESUMEN
Glycation of proteins is belived to be involved in the pathogenesis of diabetic complications, and thus the development of potent inhibitors of protein glycation is highly desirable. We tested the inhibitory effects of 12 hydrazide compounds against protein glycation and compared them with the effects of aminoguanidine (AG), a well-known inhibitor. When bovine serum albumin (BSA) was incubated with 100 mmol/l mannose for 10 days at 37 degrees C in the presence and absence of hydrazide compounds or AG at 1 mmol/l, only p-anisic hydrazide inhibited Amadori product formation. On the other hand, 8 hydrazides as well as AG inhibited the formation of advanced glycation end products (AGEs). 8-Quinolinecarboxylic hydrazide (8-QCH), the most potent hydrazide, was more effective than AG. Neither 8-QCH nor AG affected the spontaneous decrease in Amadori products of preglycated BSA in the absence of sugar, but suppressed the spontaneous increase in AGEs from preglycated BSA, with higher potency of 8-QCH relative to AG. The results indicate that 8-QCH is a more potent inhibitor of AGE formation than AG and suggest that the inhibition mechanisms of 8-QCH and AG resemble each other.
Asunto(s)
Glicoproteínas/síntesis química , Guanidinas/química , Albúmina Sérica Bovina/química , Estimulación QuímicaRESUMEN
During the past 10 years, we have experienced 110 bladder tumor cases. Among them, 70 patients were diagnosed superficial bladder tumor. Of these 70 cases, 30 were treated with intravesical adriamycin (ADR) and peplomycin (PEP), 13 with ADR only and one case with PEP and remaining 26 with TUR and hydrostatic pressure technique. We studied the efficacy of combination intravesical chemotherapy with ADR and PEP and other treatments in the prevention of recurrence in the superficial bladder tumor cases. The recurrence rate during 3 years of each group, was 25% in the group treated with ADR and PEP, 35% with ADR and 55% in remaining group. 3 years recurrence rate in the group treated with ADR and PEP was significantly low than that in the group tread with TUR and hydrostatic pressure technique alone (Wilcoxon test). Side effects was pollakisuria, pain after micturition and others. Anaphylactic shock appeared in one case. From these results we concluded that intravesical chemotherapy with combined agents is more effective than that with a single one or no treatment after TUR.